Daily Archives: December 13, 2020
Randomized trial: Baricitinib plus remdesivir reduce recovery time in patients with COVID-19
13 Dec, 2020 | 23:31h | UTCBaricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine
Commentary: Baricitinib plus remdesivir shows promise for treating COVID-19 – NIH News Releases
Commentary on Twitter
Not sure how to interpret a trial for a drug plus Remdesivir vs Remdesivir alone when you don't know if Remdesivir works. @NEJM today for this combo, which has already received FDA EUAhttps://t.co/tpmHPFPJX1 pic.twitter.com/Tmue99oJnV
— Eric Topol (@EricTopol) December 11, 2020
Call for action: Managing the infodemic – A global movement to promote access to health information and mitigate harm from health misinformation among online and offline communities
13 Dec, 2020 | 23:34h | UTCCall for Action: Managing the Infodemic – World Health Organization
See also: Infodemic Management – World Health Organization AND Tips for professional reporting on COVID-19 vaccines – World Health Organization
Meta-analysis: Efficacy and harms of remdesivir for the treatment of COVID-19. “Until stronger evidence emerges, we cannot conclude that remdesivir is efficacious for treating COVID-19”.
13 Dec, 2020 | 23:27h | UTC
Video: Coronavirus vaccine update with Anthony Fauci
13 Dec, 2020 | 23:25h | UTCCoronavirus Vaccine Update With Anthony Fauci – JAMA
A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19 – corticosteroid treatment is not recommended for patients with mild or moderate COVID-19
13 Dec, 2020 | 23:26h | UTC
Fauci says herd immunity possible by fall, ‘normality’ by end of 2021
13 Dec, 2020 | 23:23h | UTCFauci says herd immunity possible by fall, ‘normality’ by end of 2021 – The Harvard Gazette
A doctor on 9 things that could go wrong with the new vaccines – by worrying together, we can prevent much of this from happening
13 Dec, 2020 | 23:21h | UTCA doctor on 9 things that could go wrong with the new vaccines – Vox
NICE Guideline: Osteoarthritis care and management
13 Dec, 2020 | 23:19h | UTCOsteoarthritis: care and management – National Institute for Health and Care Excellence
WHO calls on world leaders to “honor their pledge” to fund COVID-19 vaccines; South Africa raises specter of “vaccine apartheid”
13 Dec, 2020 | 23:22h | UTC
Systematic review: Tourniquet use for knee replacement surgery is probably associated with an increased risk of serious adverse events
13 Dec, 2020 | 23:17h | UTCTourniquet use for knee replacement surgery – Cochrane Library
Commentary: Featured Review: Tourniquet in knee replacement surgery
Systematic review: Among patients with advanced chronic kidney disease and uremic pruritus, gabapentinoids are the most studied treatments and show the greatest reduction in itch scores
13 Dec, 2020 | 23:16h | UTCInterventions for itch in people with advanced chronic kidney disease – Cochrane Library
Commentary: What is the best treatment for itch in people with chronic kidney disease? – Cochrane Library
The USPSTF draft statement recommends behavioral counseling interventions aimed at promoting healthy weight gain and preventing excess gestational weight gain in pregnancy
13 Dec, 2020 | 23:18h | UTCCommentary: USPSTF in favor of interventions for healthy weight gain in pregnancy
Randomized trial: Trimethoprim-Sulfamethoxazole does not benefit patients with moderate and severe idiopathic pulmonary fibrosis
13 Dec, 2020 | 23:14h | UTCCommentary: Idiopathic pulmonary fibrosis: Co-trimoxazole therapy did not prevent disease progression – MedicalResearch
Commentary on Twitter
In this RCT oral co-trimoxazole (TMP-SMX) did not reduce a composite outcome of time to death, transplant, or hospitalization vs placebo in patients w moderate- severe idiopathic pulmonary fibrosis (#IPF) https://t.co/fsNxwynG1s @MarkSpe90122390
— JAMA (@JAMA_current) December 9, 2020
Randomized trial: Budesonide orodispersible tablets maintain remission in patients with eosinophilic esophagitis
13 Dec, 2020 | 23:12h | UTCEditorial: Maintenance Topical Steroid Therapy in Eosinophilic Esophagitis: Not So Hard to Swallow Any More?
Commentary: Budesonide for Maintaining EoE Remission – gutsandgrowth
Commentary on Twitter
In a phase 3 trial, up to 48 weeks of treatment with BOT was superior to placebo in maintaining remission of #EoE https://t.co/vewrFYgIG9 pic.twitter.com/P1DzdWb2vH
— Gastroenterology (@AGA_Gastro) November 25, 2020
Supplement: Lupus in the 21st Century
13 Dec, 2020 | 23:13h | UTCHomepage: Lupus in the 21st Century
Editorial: Lupus in the 21st century
- Classifying and diagnosing systemic lupus erythematosus in the 21st century
- New biomarkers in SLE: from bench to bedside
- Treatment targets in SLE: remission and low disease activity state
- Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors
- Lupus nephritis: clinical presentations and outcomes in the 21st century
- The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
- The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
- Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs